We reported that DNA-damaging agents increase PDL1 various tumor cell lines [14] and here in the mouse GL261 GBM line using rabusertib (Figure 1B), demonstrating that these cell lines do not have an atypical PDL1 response to DNA damage. The gene discussed is CD274; the disease is glioblastoma.